Chronic Faecal Incontinence – Review of the Disease State, Therapeutic Alternatives and Algorithmic Approach to Treatment

Faecal incontinence (FI) may be defined as the recurrent uncontrolled passage of faecal material, normally of one month’s duration or greater, in...

Natriuretic Peptides – Addressing the Dilemma of Heart Failure Management

Despite recent advances in therapy, heart failure (HF) remains a major cardiovascular epidemic worldwide. The increasing prevalence of the syndrome...

Antifungal Treatment in the Blood and Marrow Transplant Setting -Perspectives from Clinical Experience

Who Is At Risk and Why? Daniel Couriel (The Sarah Cannon Cancer Center, Nashville, TN, US) reviewed recently published data from the Transplant...

Individualised Antiplatelet Therapy – Is There a Role for Platelet Function Testing in Routine Clinical Practice?

Antiplatelet therapy is the standard of care for patients with acute coronary syndromes (ACS) and/or patients undergoing percutaneous coronary...

Drug-eluting Balloon Analysis

The Elutax© is a rapid exchange percutaneous transluminal coronary angioplasty (PTCA) catheter. There are two versions: one for standardsize...

Pre-clinical and Clinical Study Results for the Coracto™ Rapamycin-eluting Stent – A New-generation Drug-eluting Stent

Coronary stent implantation is one of the most important developments in the field of percutaneous coronary revascularisation after the introduction...

Drug-coated Balloons – History and Peripheral Vascular Opportunities

One of the most innovative fields of modern medical research is the percutaneous transluminal treatment of vascular disease. Coronary angioplasty was...

Advances in New Stent Designs without a Permanent Polymer May Solve Polymer-related Complications

The introduction of bare-metal stents (BMS) provided a solution to the notable limitations of balloon angioplasty in patients undergoing percutaneous...

A New Fixed-wire, ‘Stent-on-a-wire’, Very-low-profile Stent Delivery System –Rationale, Design and Update

Coronary artery stenting has evolved substantially since the first use of coronary stenting as an adjunct to balloon angioplasty in the early 1990s....

Differential Drug-eluting Stent Effects in Patients with Diabetes – Bench-to-bedside Evidence for Neointimal Suppression and Restenosis Reduction

Patients with diabetes have abnormalities in the growth and function of arterial smooth-muscle and endothelial cells and consequently have a...

123456789…next ›last »
Syndicate content
Copyright® 2012 Touch Group PLC. All rights reserved.
Touch Neurology is for informational purposes and should not be considered medical advice, diagnosis or treatment recommendations.